AST-035

N/A

Report date: 2025/07/30 15:39:24
NME

Base Information

Drug NameAST-035
Drug Alias NameAST-035
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, HepatocellularGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrogen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAstrogen Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A